Interaction of Irinotecan (CPT-11) and Its Active Metabolite 7-Ethyl-10-Hydroxycamptothecin (SN-38) with Human Cytochrome P450 Enzymes

Authors:
  • SOShogo Ozawa
    Shogo Ozawa
  • HJHideto Jinno
    Hideto Jinno
  • TTToshiko Tanaka-Kagawa
    Toshiko Tanaka-Kagawa
  • TNTetsuji Nishimura
    Tetsuji Nishimura
  • MAMasanori Ando
    Masanori Ando
  • JSJun-Ichi Sawada
    Jun-Ichi Sawada

Abstract
The influence of pro-inflammatory cytokines on alpha class glutathione S-transferase A1 and A2 (GSTA1/A2) expression was examined in human colonic epithelial cells (Caco-2) in culture. Dose-dependent reductions in GSTA1/A2 mRNA, protein, and activity levels occurred in Caco-2 cells cultured in conditioned medium (CM) from lipopolysaccharide-stimulated murine monocyte-macrophage cells (RAW 264.7). Neutralizing anti-interleukin-1β (IL-1β) antibodies attenuated this repression of GSTA1/A2 expression by CM. Moreover, recombinant human IL-1β reduced GSTα expression at the mRNA, protein, and activity levels in a dose-related fashion. Reduction of GSTA1/A2 mRNA levels by IL-1β was attenuated by pretreatment with IL-1 receptor antagonist. GSTA1/A2 mRNA half-lives were similar in control and IL-1β-treated cells, indicating that IL-1β has no effect on mRNA stability. In reporter gene studies, IL-1β caused a dose-related reduction of luciferase activity in Caco-2 cells transfected with the full-length GSTA1 promoter-luciferase construct. Using truncated constructs, IL-1β responsiveness was mapped to a region 286 base pairs upstream to the coding region. Deletion of a hepatic nuclear factor 1 (HNF-1) site in this region abrogated the IL-1β-mediated repression of GSTA1 promoter activity. These results demonstrate that IL-1β down-regulates GSTA1/A2 expression in cultured human enterocytes by a transcriptional mechanism involving an HNF-1 site.

This publication has 27 references indexed in Scilit: